These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1840063)

  • 1. Extracorporeal methods in lipid reduction pursuant to improvement in risk factors associated with atherosclerosis.
    Lobdell DD
    J Clin Apher; 1991; 6(4):211-5. PubMed ID: 1840063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.
    Alaupovic P; Fesmire JD; Hunnighake D; Domanski M; Forman S; Knatterud GL; Forrester J; Herd JA; Hoogwerf B; Campeau L; Gobel FL
    Atherosclerosis; 1999 Oct; 146(2):369-79. PubMed ID: 10532693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiology of lipid transport in plasma].
    Patsch JR
    Wien Med Wochenschr Suppl; 1989; 105():3-7. PubMed ID: 2694629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lp(a) as a marker for coronary heart disease risk.
    Scanu AM
    Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I35-9. PubMed ID: 1828399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are lipoprotein profile and lipoprotein (a) levels altered in men with psoriasis?
    Seçkin D; Tokgözoğlu L; Akkaya S
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):445-9. PubMed ID: 8077470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of lipoprotein(a) in assessment of risk for atherosclerosis].
    Kullich W; Machreich K
    Wien Med Wochenschr; 1994; 144(17):407-11. PubMed ID: 7839688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of atherosclerosis.
    Homma Y
    J Atheroscler Thromb; 2004; 11(5):265-70. PubMed ID: 15557708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolism and clinical significance of lipoprotein Lp(a) (author's transl)].
    Krempler F
    Acta Med Austriaca; 1980; 7(4-5):101-3. PubMed ID: 6454320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoprotein(a): a link between thrombosis and atherosclerosis?].
    Hansen PR
    Ugeskr Laeger; 1993 May; 155(20):1527-30. PubMed ID: 8316983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of family history of atherosclerosis with atherogenic lipid traits in men with non-coronary atherosclerosis.
    Sentí M; Pedro-Botet J; Pavesi M; Marrugat J; Aubó C; Pena A; Martín S; Rubiés-Prat J
    Clin Chim Acta; 1997 Aug; 264(2):193-205. PubMed ID: 9293377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
    Pokrovsky SN; Afanasieva OI; Safarova MS; Balakhonova TV; Matchin YG; Adamova IYU; Konovalov GA; Ezhov MV
    Atheroscler Suppl; 2017 Nov; 30():166-173. PubMed ID: 29096833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) and atherosclerosis.
    Scanu AM; Lawn RM; Berg K
    Ann Intern Med; 1991 Aug; 115(3):209-18. PubMed ID: 1829339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipoprotein(a): structure, metabolism and atherosclerotic disease].
    Postorino G; Altavilla R
    Minerva Med; 1992 Oct; 83(10):581-8. PubMed ID: 1461528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipids, lipoproteins and atherosclerosis].
    Fruchart JC
    J Mal Vasc; 1991; 16(4):325-34. PubMed ID: 1838761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of potentially atherogenic triglyceride-rich lipoprotein particles].
    Alaupovic P; Blankenhorn DH
    Klin Wochenschr; 1990; 68 Suppl 22():38-42. PubMed ID: 2087077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is lipoprotein (a)-apheresis useful?
    Bambauer R
    Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
    Dahlen GH; Guyton JR; Attar M; Farmer JA; Kautz JA; Gotto AM
    Circulation; 1986 Oct; 74(4):758-65. PubMed ID: 2944670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radical therapy of refractory hyperlipidemia: extracorporeal cholesterol elimination].
    Kostner KM
    Wien Med Wochenschr; 1994; 144(12-13):333-5. PubMed ID: 8650940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a).
    Wong WL; Eaton DL; Berloui A; Fendly B; Hass PE
    Clin Chem; 1990 Feb; 36(2):192-7. PubMed ID: 2137383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid pattern.
    von Dryander M; Fischer S; Passauer J; Müller G; Bornstein SR; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):39-44. PubMed ID: 23357139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.